Výsledky vyhledávání - "Kidney Neoplasms/pathology"

Optimal treatment duration in metastatic renal cell carcinoma patients responding to immune checkpoint inhibitors: should we treat beyond two years?

Autoři: Decruyenaere, Alexander Gennigens, Christine Sylvie, Rottey a další

Přispěvatelé: Decruyenaere, Alexander Gennigens, Christine Sylvie, Rottey a další

Zdroj: Acta Oncologica, Vol 64 (2025)
Acta oncologica
ACTA ONCOLOGICA

Témata: Male, Immune Checkpoint Inhibitors/administration & dosage, Radiology, Nuclear Medicine and Imaging, Time Factors, Oncologie, THERAPY, Carcinoma, Renal Cell/secondary, immune checkpoint inhibitors, Antineoplastic Combined Chemotherapy Protocols, Medicine and Health Sciences, Ipilimumab/administration & dosage, Human health sciences, Kidney Neoplasms/mortality, Immune Checkpoint Inhibitors, RC254-282, Aged, 80 and over, OUTCOMES, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Carcinoma, Renal Cell/pathology, Hematology, Antineoplastic Combined Chemotherapy Protocols/administration & dosage, Middle Aged, Kidney Neoplasms, Progression-Free Survival, Renal cell carcinoma, Nivolumab/administration & dosage, treatment discontinuation, Carcinoma, Renal Cell/mortality, Kidney Neoplasms/drug therapy, Nivolumab, optimal treatment duration, Oncology, Female, Life Sciences & Biomedicine, Adult, DISCONTINUATION, Sciences de la santé humaine, Kidney Neoplasms/pathology, Immune Checkpoint Inhibitors/adverse effects, 3211 Oncology and carcinogenesis, Humans, 1112 Oncology and Carcinogenesis, Oncology & Carcinogenesis, Carcinoma, Renal Cell, Retrospective Studies, Aged, Science & Technology, Duration of Therapy, Immune Checkpoint Inhibitors/therapeutic use, Ipilimumab, MELANOMA PATIENTS, Carcinoma, Renal Cell/drug therapy, Human medicine, Antineoplastic Combined Chemotherapy Protocols/therapeutic use, Follow-Up Studies

Popis souboru: application/pdf

Přístupová URL adresa: https://doaj.org/article/f0b66be9934249d38e034df42f696b62
https://hdl.handle.net/2268/335276
https://doi.org/10.2340/1651-226X.2025.43876
https://repository.uantwerpen.be/docstore/d:irua:30312
https://hdl.handle.net/10067/2161490151162165141
http://hdl.handle.net/1942/46632
http://hdl.handle.net/1854/LU-01K3QQRTE94KZYP1CX1X0WZ5CD
https://biblio.ugent.be/publication/01K3QQRTE94KZYP1CX1X0WZ5CD/file/01K42SV66F3YD38FGWT899GJ86
https://biblio.ugent.be/publication/01K3QQRTE94KZYP1CX1X0WZ5CD
http://doi.org/10.2340/1651-226x.2025.43876

Metastatic risk in clear cell renal cell carcinoma: a tool incorporating sex, size, and grade: a tool incorporating sex, size, and grade

Autoři: Frederik F. Thomsen Marcus Westerberg Rasmus D. Petersson a další

Zdroj: Thomsen, F F, Westerberg, M, Petersson, R D, Bak, R, Lindholst, J B, Al-Husseinawi, H, Heeno, E & Azawi, N H 2025, 'Metastatic risk in clear cell renal cell carcinoma : a tool incorporating sex, size, and grade', BJU International, vol. 135, no. 5, pp. 760-765. https://doi.org/10.1111/bju.16624

Témata: Male, Adult, renal cell carcinoma, Denmark, Risk Assessment, clear cell, tumour size, Kidney Neoplasms/pathology, 03 medical and health sciences, Sex Factors, 0302 clinical medicine, Risk Factors, 80 and over, Humans, Neoplasm Metastasis, Carcinoma, Renal Cell, Aged, grade, Aged, 80 and over, Renal Cell/pathology, Carcinoma, Middle Aged, Denmark/epidemiology, Kidney Neoplasms, metastatic, Tumor Burden, Female, Neoplasm Grading

Přístupová URL adresa: https://pubmed.ncbi.nlm.nih.gov/39703075

Outcomes of Patients with Brain Metastases from Renal Cell Carcinoma Receiving First-line Therapies: Results from the International Metastatic Renal Cell Carcinoma Database Consortium: Results from the International Metastatic Renal Cell Carcinoma Database Consortium

Autoři: Takemura, Kosuke Lemelin, Audreylie Ernst, Matthew S. a další

Zdroj: Takemura, K, Lemelin, A, Ernst, M S, Wells, J C, Saliby, R M, El Zarif, T, Labaki, C, Basappa, N S, Szabados, B, Powles, T, Davis, I D, Wood, L A, Lalani, A K A, McKay, R R, Lee, J L, Meza, L, Pal, S K, Donskov, F, Yuasa, T, Beuselinck, B, Gebrael, G, Agarwal, N, Choueiri, T K & Heng, D Y C 2024, 'Outcomes of Patients with Brain Metastases from Renal Cell Carcinoma Receiving First-line Therapies : Results from the International Metastatic Renal Cell Carcinoma Database Consortium', European Urology, vol. 86, no. 6, pp. 488-492. https://doi.org/10.1016/j.eururo.2024.01.006

Témata: Male, Databases, Factual, Neurosurgery, Radiosurgery, Kidney Neoplasms/pathology, Databases, Immune checkpoint inhibitors, Humans, Carcinoma, Renal Cell, Factual, Aged, Retrospective Studies, 2. Zero hunger, Science & Technology, Brain Neoplasms, Carcinoma, 3202 Clinical sciences, 1103 Clinical Sciences, Urology & Nephrology, Middle Aged, Renal cell carcinoma, Kidney Neoplasms, 3. Good health, Survival Rate, Brain neoplasms, Treatment Outcome, Renal Cell/secondary, Brain Neoplasms/secondary, Female, Life Sciences & Biomedicine

Přístupová URL adresa: https://pubmed.ncbi.nlm.nih.gov/38290965

Tivozanib Monotherapy in the Frontline Setting for Patients with Metastatic Renal Cell Carcinoma and Favorable Prognosis

Autoři: Ricky Frazer José Ángel Arranz Sergio Vázquez Estévez a další

Přispěvatelé: Ricky Frazer José Ángel Arranz Sergio Vázquez Estévez a další

Zdroj: Curr Oncol Rep

Témata: Tyrosine kinase inhibitors, 0301 basic medicine, Checkpoint inhibitors, Phenylurea Compounds/therapeutic use [MeSH], Quinolines/therapeutic use [MeSH], Humans [MeSH], Tivozanib, Kidney Neoplasms/pathology [MeSH], Protein Kinase Inhibitors/therapeutic use [MeSH], Kidney Neoplasms/drug therapy [MeSH], Carcinoma, Renal Cell/drug therapy [MeSH], Quality of Life [MeSH], Metastatic renal cell carcinoma, Prognosis [MeSH], Receptors, Vascular Endothelial Growth Factor/antagonists, Topical Collection on Genitourinary Cancers, First-line treatment, Review, Carcinoma, Renal Cell/secondary [MeSH], Favorable risk, Receptors, Vascular Endothelial Growth Factor/therapeutic use [MeSH], Phenylurea Compounds, Prognosis, Kidney Neoplasms, 03 medical and health sciences, Receptors, Vascular Endothelial Growth Factor, 0302 clinical medicine, Quinolines, Quality of Life, Humans, Carcinoma, Renal Cell, Protein Kinase Inhibitors

Popis souboru: application/pdf; text/xml

Přístupová URL adresa: https://pubmed.ncbi.nlm.nih.gov/39565522
https://repository.publisso.de/resource/frl:6506953

Prise en charge du cancer du rein en 2025

Autoři: Wick, Manon Denis, Chloé Freres, Pierre a další

Témata: Kidney Neoplasms/therapy, Kidney Neoplasms/pathology, Kidney Neoplasms/epidemiology, Oncology, Survival outcome, Oncologie, Tyrosine kinase inhibitor, Humans, Immunotherapy, Human health sciences, Sciences de la santé humaine, Renal cell carcinoma, Kidney Neoplasms/diagnosis

Přístupová URL adresa: https://hdl.handle.net/2268/334821

Characterization of Patients with Metastatic Renal Cell Carcinoma Undergoing Deferred, Upfront, or No Cytoreductive Nephrectomy in the Era of Combination Immunotherapy: Results from the International Metastatic Renal Cell Carcinoma Database Consortium: Results from the International Metastatic Renal Cell Carcinoma Database Consortium

Autoři: Kosuke Takemura Matthew S. Ernst Vishal Navani a další

Zdroj: Takemura, K, Ernst, M S, Navani, V, Wells, J C, Bakouny, Z, Donskov, F, Basappa, N S, Wood, L A, Meza, L, Pal, S K, Szabados, B, Powles, T, Beuselinck, B, McKay, R R, Lee, J L, Ernst, D S, Kapoor, A, Yuasa, T, Choueiri, T K & Heng, D Y C 2024, 'Characterization of Patients with Metastatic Renal Cell Carcinoma Undergoing Deferred, Upfront, or No Cytoreductive Nephrectomy in the Era of Combination Immunotherapy : Results from the International Metastatic Renal Cell Carcinoma Database Consortium', European Urology Oncology, vol. 7, no. 3, pp. 501-508. https://doi.org/10.1016/j.euo.2023.10.002

Témata: Male, Databases, Factual, Carcinoma, Renal Cell/therapy, Cytoreduction Surgical Procedures, Middle Aged, Cytoreduction surgical procedures, Prognosis, Nephrectomy, Combined Modality Therapy, Renal cell carcinoma, Kidney Neoplasms, 3. Good health, Kidney Neoplasms/pathology, Immune checkpoint inhibitors, Databases, Immunotherapy/methods, Humans, Female, Immunotherapy, Carcinoma, Renal Cell, Factual, Aged, Retrospective Studies

Přístupová URL adresa: https://pubmed.ncbi.nlm.nih.gov/37914579
https://portal.findresearcher.sdu.dk/da/publications/37001930-8cbd-436b-adad-fe7d72d157e3
https://doi.org/10.1016/j.euo.2023.10.002
https://pure.au.dk/portal/en/publications/7dae8574-a9db-46d8-b9d6-77e0c1cc944f
https://doi.org/10.1016/j.euo.2023.10.002

Sarcomatoid Dedifferentiation as a Predictor of Cancer-Specific Mortality in Surgically Treated Localized Renal Cell Carcinoma

Autoři: Incesu R. -B. Morra S. Scheipner L. a další

Zdroj: Ann Surg Oncol

Témata: Male, Tumor grade, Cancer-specific mortality, Cell Dedifferentiation, Middle Aged, Prognosis, Nephrectomy, Renal cell carcinoma, Kidney Neoplasms, 3. Good health, Survival Rate, Sarcomatoid dedifferentiation, 03 medical and health sciences, 0302 clinical medicine, Female [MeSH], Follow-Up Studies [MeSH], Neoplasm Grading [MeSH], Aged [MeSH], SEER Program [MeSH], Humans [MeSH], Kidney Neoplasms/surgery [MeSH], Kidney Neoplasms/pathology [MeSH], Middle Aged [MeSH], Nephrectomy/mortality [MeSH], Survival Rate [MeSH], Carcinoma, Renal Cell/mortality [MeSH], Urologic Oncology, Male [MeSH], Kidney Neoplasms/mortality [MeSH], Prognosis [MeSH], Carcinoma, Renal Cell/pathology [MeSH], Carcinoma, Renal Cell/surgery [MeSH], Cell Dedifferentiation [MeSH], Humans, Female, Neoplasm Grading, Carcinoma, Renal Cell, Aged, Follow-Up Studies, SEER Program

Přístupová URL adresa: https://pubmed.ncbi.nlm.nih.gov/38773038
https://hdl.handle.net/11588/973406
https://hdl.handle.net/2434/1124095
https://doi.org/10.1245/s10434-024-15431-5
https://repository.publisso.de/resource/frl:6503491
https://hdl.handle.net/11588/973406
https://doi.org/10.1245/s10434-024-15431-5

Real-World Impact of Upfront Cytoreductive Nephrectomy in Metastatic Non-Clear Cell Renal Cell Carcinoma Treated with First-Line Immunotherapy Combinations or Tyrosine Kinase Inhibitors (A Sub-Analysis from the ARON-1 Retrospective Study)

Autoři: Fiala, Ondřej Buti, Sebastiano Bamias, Aristotelis a další

Přispěvatelé: Fiala, Ondřej Buti, Sebastiano Bamias, Aristotelis a další

Zdroj: Target Oncol
Targeted oncology, Vol. 19, no.4, p. 587-599 (2024)

Témata: Male, Adult, Aged, 80 and over, eventually, Cytoreduction Surgical Procedures, Tyrosine Kinase Inhibitors, Middle Aged, non clear cell renal cell carcinoma. nccRCC, Nephrectomy, Kidney Neoplasms, tyrosine kinase inhibitor monotherapy might be preferred, Female [MeSH], Aged, 80 and over [MeSH], Aged [MeSH], Protein Kinase Inhibitors/pharmacology [MeSH], Adult [MeSH], Humans [MeSH], Neoplasm Metastasis [MeSH], Cytoreduction Surgical Procedures/methods [MeSH], Retrospective Studies [MeSH], Kidney Neoplasms/pathology [MeSH], Middle Aged [MeSH], Protein Kinase Inhibitors/therapeutic use [MeSH], Tyrosine Kinase Inhibitors [MeSH], Kidney Neoplasms/drug therapy [MeSH], Immunotherapy/methods [MeSH], Nephrectomy/methods [MeSH], Carcinoma, Renal Cell/drug therapy [MeSH], Male [MeSH], Original Research Article, Patients with metastatic renal cell carcinoma of non-clear cell histology undergoing cytoreductive nephrectomy prior to systemic therapy have better outcomes compared with those treated with systemic therapy alone. For patients who are not candidates for cytoreductive nephrectomy, Humans, Female, Immunotherapy, Neoplasm Metastasis, immunotherapy plus tyrosine kinase inhibitor combination or, Carcinoma, Renal Cell, Protein Kinase Inhibitors, Retrospective Studies, Aged

Popis souboru: application/pdf

Přístupová URL adresa: https://pubmed.ncbi.nlm.nih.gov/38704759
https://hdl.handle.net/11588/982208
https://hdl.handle.net/2078.1/304379
https://pergamos.lib.uoa.gr/uoa/dl/object/3483660
https://repository.publisso.de/resource/frl:6491620

First-line immune-based combinations or sunitinib in favorable-risk metastatic renal cell carcinoma: a real-world retrospective comparison from the ARON-1 study

Autoři: Roviello, Giandomenico Molina-Cerrillo, Javier Massari, Francesco a další

Přispěvatelé: Roviello, Giandomenico Molina-Cerrillo, Javier Massari, Francesco a další

Zdroj: Cancer Immunol Immunother
Cancer Immunology, Immunotherapy, Vol 74, Iss 2, Pp 1-11 (2025)

Témata: Adult, Male, ARON-1 study, Good favorable-risk IMDC criteria, Immune-based combinations, Immunotherapy, Renal cell carcinoma, Pyridines, Risk Factors, Antineoplastic Combined Chemotherapy Protocols, Sunitinib, Humans, Neoplasm Metastasis, Carcinoma, Renal Cell, Immune Checkpoint Inhibitors, Protein Kinase Inhibitors, RC254-282, Aged, Retrospective Studies, Immune-based combination, Research, Phenylurea Compounds, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Pyridines [MeSH], Kidney Neoplasms/immunology [MeSH], Phenylurea Compounds/therapeutic use [MeSH], Aged [MeSH], Kidney Neoplasms/pathology [MeSH], Risk Factors [MeSH], Carcinoma, Renal Cell/mortality [MeSH], Male [MeSH], Kidney Neoplasms/mortality [MeSH], Female [MeSH], Quinolines/therapeutic use [MeSH], Adult [MeSH], Humans [MeSH], Neoplasm Metastasis [MeSH], Sunitinib/therapeutic use [MeSH], Carcinoma, Renal Cell/immunology [MeSH], Retrospective Studies [MeSH], Middle Aged [MeSH], Protein Kinase Inhibitors/therapeutic use [MeSH], Antineoplastic Combined Chemotherapy Protocols/therapeutic use [MeSH], Immune Checkpoint Inhibitors/therapeutic use [MeSH], Kidney Neoplasms/drug therapy [MeSH], Carcinoma, Renal Cell/drug therapy [MeSH], Prognosis [MeSH], Quinolines/administration, Phenylurea Compounds/administration, Middle Aged, Prognosis, Kidney Neoplasms, Settore MEDS-09/A - Oncologia medica, Quinolines, Female

Popis souboru: application/pdf; application/vnd.openxmlformats-officedocument.wordprocessingml.document

Přístupová URL adresa: https://pubmed.ncbi.nlm.nih.gov/39752009
https://doaj.org/article/eb936d9a07a145879e1399104860116a
https://repository.publisso.de/resource/frl:6502083
https://link.springer.com/article/10.1007/s00262-024-03897-x
https://hdl.handle.net/11585/1000358
https://doi.org/10.1007/s00262-024-03897-x

Perioperative Complications and In-Hospital Mortality in Partial and Radical Nephrectomy Patients with Heart-Valve Replacement

Autoři: Siech, Carolin Baudo, Andrea de Angelis, Mario a další

Zdroj: Ann Surg Oncol

Témata: Male, Heart Valve Prosthesis Implantation, Length of Stay/statistics, Comorbidities, Aged [MeSH], Heart-valve replacement, Postoperative Complications/mortality [MeSH], Kidney Neoplasms/pathology [MeSH], Risk Factors [MeSH], Heart Valve Prosthesis Implantation/mortality [MeSH], Nephrectomy/mortality [MeSH], Hospital Mortality [MeSH], Nephrectomy/methods [MeSH], Male [MeSH], Intraoperative Complications/mortality [MeSH], Kidney Neoplasms/mortality [MeSH], Nephrectomy/adverse effects [MeSH], Heart surgery, Postoperative Complications/etiology [MeSH], NIS, Female [MeSH], Follow-Up Studies [MeSH], Humans [MeSH], Kidney Neoplasms/surgery [MeSH], Middle Aged [MeSH], Kidney cancer, Survival Rate [MeSH], Heart Valve Prosthesis Implantation/adverse effects [MeSH], Urologic Oncology, Prognosis [MeSH], Middle Aged, Length of Stay, Prognosis, Nephrectomy, Kidney Neoplasms, Survival Rate, 03 medical and health sciences, Postoperative Complications, 0302 clinical medicine, Risk Factors, Humans, Female, Hospital Mortality, Intraoperative Complications, Aged, Follow-Up Studies

Přístupová URL adresa: https://pubmed.ncbi.nlm.nih.gov/38526833
https://repository.publisso.de/resource/frl:6504123

Prise en charge du cancer du rein en 2025. ; Recommendations for the management of kidney cancer in 2025.

Autoři: Wick, Manon Denis, Chloé Freres, Pierre a další

Zdroj: Revue Médicale de Liège, 80 (5-6), 323 - 329 (2025-05)

Témata: Immunotherapy, Renal cell carcinoma, Survival outcome, Tyrosine kinase inhibitor, Humans, Kidney Neoplasms/therapy, Kidney Neoplasms/diagnosis, Kidney Neoplasms/epidemiology, Kidney Neoplasms/pathology, Human health sciences, Oncology, Sciences de la santé humaine, Oncologie

Relation: urn:issn:0370-629X; urn:issn:2566-1566; https://orbi.uliege.be/handle/2268/334821; info:hdl:2268/334821; info:pmid:40518885

Dostupnost: https://orbi.uliege.be/handle/2268/334821
https://orbi.uliege.be/bitstream/2268/334821/1/M-Wick_2025_80_5-6_0.pdf

Early kinetics of C-reactive protein as prognosticator for survival in a real-world cohort of patients with metastatic renal cell cancer under first-line therapy with immune checkpoint inhibitors

Autoři: Vayda Schüttke Cathrin Kusiek Susanne Fuessel a další

Zdroj: Clin Transl Oncol

Témata: C-Reactive Protein, Humans, Humans [MeSH], Retrospective Studies [MeSH], Kidney Neoplasms/pathology [MeSH], Prognosis, Immune Checkpoint Inhibitors/therapeutic use [MeSH], Biomarker, Immunotherapy, Metastatic renal cell carcinoma, Prognosis [MeSH], C-Reactive Protein/analysis [MeSH], Tyrosine kinase inhibitors, CRP kinetics, Carcinoma, Renal Cell/pathology [MeSH], Research Article, The Immune System and Cancer\\Immunotherapy, Carcinoma, Renal Cell, Immune Checkpoint Inhibitors, Kidney Neoplasms, 3. Good health, Retrospective Studies

Přístupová URL adresa: https://pubmed.ncbi.nlm.nih.gov/37695463
https://repository.publisso.de/resource/frl:6500491

Outcomes for International Metastatic Renal Cell Carcinoma Database Consortium Prognostic Groups in Contemporary First-line Combination Therapies for Metastatic Renal Cell Carcinoma

Autoři: Ernst, Matthew S. Navani, Vishal Wells, J. Connor a další

Přispěvatelé: Ernst, Matthew S. Navani, Vishal Wells, J. Connor a další

Zdroj: Scientia
Scientia. Dipòsit d'Informació Digital del Departament de Salut
instname
Ernst, M S, Navani, V, Wells, J C, Donskov, F, Basappa, N, Labaki, C, Pal, S K, Meza, L, Wood, L A, Ernst, D S, Szabados, B, McKay, R R, Parnis, F, Suarez, C, Yuasa, T, Lalani, A K, Alva, A, Bjarnason, G A, Choueiri, T K & Heng, D Y C 2023, 'Outcomes for International Metastatic Renal Cell Carcinoma Database Consortium Prognostic Groups in Contemporary First-line Combination Therapies for Metastatic Renal Cell Carcinoma', European Urology, vol. 84, no. 1, pp. 109-116. https://doi.org/10.1016/j.eururo.2023.01.001

Témata: Vascular Endothelial Growth Factor A, Metastatic renal cell carcinoma, TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS::terapéutica::farmacoterapia::farmacoterapia combinada, Ronyons - Càncer - Tractamemt, Prognostication, Quimioteràpia combinada, ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT::Therapeutics::Drug Therapy::Drug Therapy, Combination, Kidney Neoplasms/pathology, 03 medical and health sciences, 0302 clinical medicine, ENFERMEDADES::neoplasias::neoplasias por localización::neoplasias urogenitales::neoplasias urológicas::neoplasias renales, COMPUESTOS QUÍMICOS Y DROGAS::acciones y usos químicos::acciones farmacológicas::usos terapéuticos::antineoplásicos::inmunoterapia antineoplásica, CHEMICALS AND DRUGS::Chemical Actions and Uses::Pharmacologic Actions::Therapeutic Uses::Antineoplastic Agents::Antineoplastic Agents, Immunological, Humans, DISEASES::Neoplasms::Neoplasms by Site::Urogenital Neoplasms::Urologic Neoplasms::Kidney Neoplasms, Carcinoma, Renal Cell, Retrospective Studies, Renal Cell/pathology, Carcinoma, Carcinoma, Renal Cell/pathology, Prognosis, Kidney Neoplasms, 3. Good health, International Metastatic Renal Cell Carcinoma Database Consortium, Vascular endothelial growth factor targeted therapy, Ronyons - Càncer - Immunoteràpia, Immunotherapy

Popis souboru: application/pdf

Přístupová URL adresa: https://pubmed.ncbi.nlm.nih.gov/36707357
https://hdl.handle.net/11351/9883
https://pure.au.dk/ws/files/411926987/1-s2.0-S0302283823000015-mainext.pdf
https://portal.findresearcher.sdu.dk/da/publications/f4c1c6a4-d198-4a17-9a06-5947c605bd65
https://doi.org/10.1016/j.eururo.2023.01.001
http://www.scopus.com/inward/record.url?scp=85147298567&partnerID=8YFLogxK
https://pure.au.dk/ws/files/411926987/1-s2.0-S0302283823000015-mainext.pdf
https://pure.au.dk/portal/en/publications/18d73768-8c29-4b06-a66f-93647ed8fb97
https://doi.org/10.1016/j.eururo.2023.01.001

Differential effect of surgical technique on intravesical recurrence after radical nephroureterectomy in patients with upper tract urothelial cancer: a systematic review and Meta-analysis

Autoři: Tsuboi, Ichiro Matsukawa, Akihiro Kardoust Parizi, Mehdi a další

Zdroj: World J Urol

Témata: Carcinoma, Transitional Cell, 03 medical and health sciences, 0302 clinical medicine, Urinary Bladder Neoplasms, Ureter/surgery [MeSH], Humans [MeSH], Kidney Neoplasms/surgery [MeSH], Kidney Neoplasms/pathology [MeSH], Urinary Bladder Neoplasms/pathology [MeSH], Upper tract urinary cancer, Radical nephroureterectomy, Intravesical recurrence, Carcinoma, Transitional Cell/pathology [MeSH], Ureteral Neoplasms/surgery [MeSH], Urinary Bladder Neoplasms/surgery [MeSH], Nephroureterectomy/methods [MeSH], Research, Carcinoma, Transitional Cell/surgery [MeSH], Neoplasm Recurrence, Local/epidemiology [MeSH], Ureteral Neoplasms, Humans, Neoplasm Recurrence, Local, Ureter, Nephroureterectomy, Kidney Neoplasms

Přístupová URL adresa: https://pubmed.ncbi.nlm.nih.gov/39162743
https://repository.publisso.de/resource/frl:6512094

Increased level of TXNIP and nuclear translocation of TXN is associated with end stage renal disease and development of multiplex renal tumours

Autoři: Tamas Beothe Janos Docs Gyula Kovacs a další

Zdroj: BMC Nephrol
BMC Nephrology, Vol 25, Iss 1, Pp 1-7 (2024)

Témata: Male, Adult, 0301 basic medicine, TXN, Active Transport, Cell Nucleus, 03 medical and health sciences, Thioredoxins, 0302 clinical medicine, Humans, Carcinoma, Renal Cell, Cancer, Aged, Cell Nucleus, End stage kidney, Research, Middle Aged, Immunohistochemistry, Diseases of the genitourinary system. Urology, Kidney Neoplasms, 3. Good health, Kidney Failure, Chronic, Female, RC870-923, Carrier Proteins, TXNIP, Female [MeSH], Aged [MeSH], Cell Nucleus/metabolism [MeSH], Adult [MeSH], Humans [MeSH], Thioredoxins/metabolism [MeSH], Kidney Neoplasms/metabolism [MeSH], Kidney Neoplasms/pathology [MeSH], Middle Aged [MeSH], Carrier Proteins/metabolism [MeSH], Kidney Failure, Chronic/metabolism [MeSH], Carcinoma, Renal Cell/metabolism [MeSH], Male [MeSH], Carcinoma, Renal Cell/pathology [MeSH], Active Transport, Cell Nucleus [MeSH]

Přístupová URL adresa: https://pubmed.ncbi.nlm.nih.gov/39020292
https://doaj.org/article/3e412ba0f73449a893c7791e0c08c4f8
https://repository.publisso.de/resource/frl:6493063

Influence of cryoablation versus operation on circulating lymphocyte subsets in patients with early-stage renal cell carcinoma

Autoři: Waidhauser, Johanna Gantner, Anna-Katharina Schifano, Paola a další

Zdroj: BMC Cancer
BMC Cancer, Vol 24, Iss 1, Pp 1-11 (2024)

Témata: Cryoablation, Male, Adult, 0301 basic medicine, CD8-Positive T-Lymphocytes, Cryosurgery, 03 medical and health sciences, 0302 clinical medicine, Humans, Flow cytometry, Lymphocytes, Prospective Studies, Lymphocyte Count, Carcinoma, Renal Cell, RC254-282, Aged, Neoplasm Staging, ddc:610, Research, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Middle Aged, Flow Cytometry, Renal cell carcinoma, Kidney Neoplasms, Lymphocyte Subsets, 3. Good health, Kidney Neoplasms/immunology [MeSH], Aged [MeSH], Flow Cytometry [MeSH], Cryosurgery/methods [MeSH], Kidney Neoplasms/pathology [MeSH], Neoplasm Staging [MeSH], Male [MeSH], Lymphocyte Subsets/immunology [MeSH], Surgery, CD8-Positive T-Lymphocytes/immunology [MeSH], Carcinoma, Renal Cell/blood [MeSH], Female [MeSH], Adult [MeSH], Lymphocyte Count [MeSH], Humans [MeSH], Prospective Studies [MeSH], Carcinoma, Renal Cell/immunology [MeSH], Treatment Outcome [MeSH], Kidney Neoplasms/surgery [MeSH], Middle Aged [MeSH], Kidney Neoplasms/blood [MeSH], Carcinoma, Renal Cell/pathology [MeSH], Carcinoma, Renal Cell/surgery [MeSH], Treatment Outcome, Female

Popis souboru: application/pdf

Přístupová URL adresa: https://pubmed.ncbi.nlm.nih.gov/38987735
https://doaj.org/article/e959e0dfc77848ba81005a545e796591
https://opus.bibliothek.uni-augsburg.de/opus4/files/114268/s12885-024-12596-w.pdf
https://doi.org/10.1186/s12885-024-12596-w
https://nbn-resolving.org/urn:nbn:de:bvb:384-opus4-1142687
https://opus.bibliothek.uni-augsburg.de/opus4/frontdoor/index/index/docId/114268
https://repository.publisso.de/resource/frl:6495312

Automation of Wilms’ tumor segmentation by artificial intelligence

Autoři: Olivier Hild Pierre Berriet Jérémie Nallet a další

Přispěvatelé: Olivier Hild Pierre Berriet Jérémie Nallet a další

Zdroj: Cancer Imaging
Cancer Imaging, Vol 24, Iss 1, Pp 1-7 (2024)
Cancer imaging, vol. 24, no. 1, pp. 83

Témata: Male, Artificial intelligence, R895-920, [INFO.INFO-SE]Computer Science [cs]/Software Engineering [cs.SE], Wilms' tumor, Wilms Tumor, [INFO.INFO-IU]Computer Science [cs]/Ubiquitous Computing, [INFO.INFO-CR]Computer Science [cs]/Cryptography and Security [cs.CR], Medical physics. Medical radiology. Nuclear medicine, Automation, 03 medical and health sciences, Segmentation, Imaging, Three-Dimensional, 0302 clinical medicine, Artificial Intelligence, Humans, 3D reconstruction, Child, RC254-282, [INFO.INFO-DC]Computer Science [cs]/Distributed, Wilms Tumor/diagnostic imaging, Wilms Tumor/pathology, Kidney Neoplasms/diagnostic imaging, Kidney Neoplasms/pathology, Tomography, X-Ray Computed/methods, Imaging, Three-Dimensional/methods, Child, Preschool, Neural Networks, Computer, Female, Deep learning, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Parallel, [INFO.INFO-MO]Computer Science [cs]/Modeling and Simulation, Kidney Neoplasms, and Cluster Computing [cs.DC], [INFO.INFO-MA]Computer Science [cs]/Multiagent Systems [cs.MA], [INFO.INFO-ET]Computer Science [cs]/Emerging Technologies [cs.ET], Tomography, X-Ray Computed, Research Article

Popis souboru: application/pdf

Přístupová URL adresa: https://pubmed.ncbi.nlm.nih.gov/38956718
https://doaj.org/article/067be545e87e4b0094ae4c6fdb69e241
https://serval.unil.ch/resource/serval:BIB_330F53FDF41C.P001/REF.pdf
http://nbn-resolving.org/urn/resolver.pl?urn=urn:nbn:ch:serval-BIB_330F53FDF41C5
https://serval.unil.ch/notice/serval:BIB_330F53FDF41C

Health-Related Quality of Life Outcomes With Two Different Starting Doses of Lenvatinib in Combination With Everolimus for Previously Treated Renal Cell Carcinoma

Autoři: Cristiane Bergerot Sun Young Rha Sumanta Pal a další

Přispěvatelé: Cristiane Bergerot Sun Young Rha Sumanta Pal a další

Zdroj: Oncologist
Repositorio Institucional de la Consejería de Sanidad de la Comunidad de Madrid
Consejería de Sanidad de la Comunidad de Madrid

Témata: Renal Cell* / drug therapy, Vascular Endothelial Growth Factor A, Renal Cell* / pathology, 3122 Cancers, Antineoplastic Agents, Genitourinary Cancer, 03 medical and health sciences, 0302 clinical medicine, Kidney Neoplasms* / drug therapy, Humans, Everolimus, Antineoplastic Agents* / administration & dosage, Carcinoma, Renal Cell, Everolimus / therapeutic use, Carcinoma, EORTC QLQ-C30, phase II, VEGF, Kidney Neoplasms, FKSI-DRS, 3. Good health, patient-reported outcomes, Quality of Life, Kidney Neoplasms* / pathology

Popis souboru: application/pdf; fulltext

Přístupová URL adresa: https://pubmed.ncbi.nlm.nih.gov/35881028
https://hdl.handle.net/20.500.12530/106835
https://trepo.tuni.fi/handle/10024/146639

External validation of yonsei nomogram predicting chronic kidney disease development after partial nephrectomy: An international, multicenter study

Autoři: Ali Abdel Raheem Isotta Landi Ibrahim Alowidah a další

Přispěvatelé: Ali Abdel Raheem Isotta Landi Ibrahim Alowidah a další

Zdroj: International Journal of Urology. 30:308-317

Témata: chronic kidney disease, external validation, functional outcomes, partial nephrectomy, Yonsei nomogram, Chronic* / surgery, Middle Aged, Nephrectomy, Kidney Neoplasms, functional outcome, 3. Good health, Nomograms, 03 medical and health sciences, 0302 clinical medicine, Nephrectomy / methods, Humans, Renal Insufficiency, Renal Insufficiency, Chronic, Kidney Neoplasms* / pathology, Retrospective Studies, Glomerular Filtration Rate

Popis souboru: application/pdf

Přístupová URL adresa: https://pubmed.ncbi.nlm.nih.gov/36478459
https://onlinelibrary.wiley.com/doi/10.1111/iju.15108
https://hdl.handle.net/11368/3038203
https://hdl.handle.net/11562/1108480
https://doi.org/10.1111/iju.15108
https://onlinelibrary.wiley.com/doi/10.1111/iju.15108
https://doi.org/10.1111/iju.15108
https://hdl.handle.net/11368/3038203
https://hdl.handle.net/11380/1294016
https://doi.org/10.1111/iju.15108
https://onlinelibrary.wiley.com/doi/10.1111/iju.15108
https://doi.org/10.1111/iju.15108
https://hdl.handle.net/11568/1206906
https://hdl.handle.net/11391/1540677
https://doi.org/10.1111/iju.15108
https://hdl.handle.net/2158/1297706
https://doi.org/10.1111/iju.15108

Clinical Implications for da Vinci SP Partial Nephrectomy in High-Complexity Tumors: Propensity Score-Matching Analysis

Autoři: Jinu Kim Joon Chae Na Jong Soo Lee a další

Přispěvatelé: Jinu Kim Joon Chae Na Jong Soo Lee a další

Zdroj: Journal of Endourology. 36:1290-1295

Témata: single-site surgery, partial nephrectomy, nephron-sparing surgery, kidney cancer, Middle Aged, Nephrectomy, Kidney Neoplasms, 03 medical and health sciences, Treatment Outcome, 0302 clinical medicine, Robotic Surgical Procedures, robotic surgery, Nephrectomy / methods, Kidney Neoplasms* / surgery, Humans, Warm Ischemia, Propensity Score, Kidney Neoplasms* / pathology, Robotic Surgical Procedures* / methods, Retrospective Studies

Přístupová URL adresa: https://pubmed.ncbi.nlm.nih.gov/35699058